Trademark: 87246841
Word
LIFELABS GENETICS
Status Date
Tuesday, April 6, 2021
Registration Number
6311559
Registration Date
Tuesday, April 6, 2021
Filing Date
Wednesday, November 23, 2016
Published for Opposition
Tuesday, August 4, 2020
9 Aliquotters, namely, manual and robotic devices for use in medical laboratories to accurately dispense liquid volumes of medical patient samples and reagents into separate specimen containers; filters for blood and blood components for laboratory use; laboratory devices implementing nucleic acid extraction, fluorescence in situ hybridization and competitive hybridization to detect genetic sequences; scientific instruments, namely, analyzers for detecting and karyotyping chromosomes; computer software for scientific analysis of genetic sequences; computer software platform for analyzing bioinformatics to interpret results of genetic testing; computer software platforms for use in generating clinical reports for genetic testing; computer communications software for connecting medical practices via the Internet to manage and share patient information relating to genetic testing orders and results; computer programs for managing requests for genetic testing, laboratory processing and laboratory equipment; computer programs for controlling quality of testing and integrity of testing results
5 drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids for the presence of lipids, carbohydrates, proteins, enzymes, acids, alcohols, metabolites, vitamins, electrolytes, heavy metals, contaminants, poisons, and toxins; diagnostic, preparations for medical research use; medical diagnostic reagents; diagnostic kits comprised of organic and inorganic medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; biological preparations for detecting genetic predispositions for medical purposes; newborn screenings, namely, genetic identity tests comprised of reagents for medical purposes; newborn screenings, namely, preparations for detecting somatic mutation in genes for medical purposes; newborn screenings, namely, preparations for detecting autoimmune diseases in genes for medical purposes; newborn screenings, namely, preparations for detecting epigenetic disorders in genes for medical purposes; newborn screenings, namely, medical diagnostic test strips for blood analysis; diagnostic biomarker reagents for analysis of genetic sequencing for medical purposes; diagnostic biomarker reagents for analysis of metabolic disorders for medical purposes; diagnostic biomarker reagents for analysis of enzyme deficiency for medical purposes
38 providing access to an electronic exchange of medical records across a nationwide health information network to enable physicians to make informed medical recommendations
35 data processing services; customer services, namely, responding to customers inquiries for others in the field of medical laboratory services; customer services, namely, responding to customers inquiries for others in the field of medical diagnostic services
1 chemically treated non-medical test strips for calibration of laboratory test equipment and medical diagnostic equipment; diagnostic preparations for medical laboratory use; diagnostic reagents for clinical and medical laboratory use; assays and reagents for use in genetic research; genetic identity tests comprised of reagents for non-medical purposes; reagents for scientific or medical research use; chemical reagents for non-medical purposes
44 consulting services in the field of genetic testing for medical purposes; consulting services in the field of medical testing for diagnostic purposes; consulting services in the field of medical screening of infants for hereditary medical disorders; medical analysis services for diagnostic and medical purposes, namely, medical analysis of, blood, body fluids, extracellular tissue specimens, stool samples, exhaled air, biopsy specimens and autopsy specimens; Medical laboratory testing of blood, body fluids, extracellular tissue specimens, stool samples, exhaled air, biopsy specimens and autopsy specimens all for diagnostic and medical purposes; medical information services, namely, reporting of patient authorized clinical testing results directly to doctors; medical analysis services of patient medical data for the diagnosis of cancer; providing medical information to doctors in the form of reports in the field of a medical diagnosis; providing healthcare information; providing medical information to patients in the field of pharmaceutical treatments; providing information relating to diagnostic properties of pharmaceuticals; providing medical information; providing health information to physicians about surgical instruments
42 medical research consulting; design and development of computer hardware and software for genetic testing, genetic sequencing, biochemical analysis, newborn screening and data processing; laboratory research in the fields of biochemistry and medical genetics; laboratory testing of materials; medical laboratory services; blood analysis services; DNA analysis services for scientific research purposes; providing medical research information in the field of patient clinical trials; providing an interactive web site featuring technology that enables users to access, monitor and generate medical information and reports; providing information relating to pharmacology consultancy
The mark consists of the stylized wording "LIFELABS" above the stylized wording "GENETICS". The letter "I" in "LIFE" is composed of a stylized stick person with a dot for a head. The letter "I" in "GENETICS" is a letter "I" inside of a circle.
LIFE LABS GENETICS
Color is not claimed as a feature of the mark.
"GENETICS"
Mar 27, 2024
Teas Change Of Correspondence Received
Mar 27, 2024
Teas Change Of Domestic Representatives Address
Mar 27, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 27, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 6, 2021
Registered-Principal Register
Mar 4, 2021
1(B) Basis Deleted; Proceed To Registration
Nov 22, 2020
Notice Of Allowance Cancelled
Mar 4, 2021
Case Assigned To Intent To Use Paralegal
Nov 22, 2020
Teas Delete 1(B) Basis Received
Sep 29, 2020
Noa E-Mailed - Sou Required From Applicant
Aug 4, 2020
Official Gazette Publication Confirmation E-Mailed
Aug 4, 2020
Published For Opposition
Jul 15, 2020
Notification Of Notice Of Publication E-Mailed
Jun 26, 2020
Law Office Publication Review Completed
Jun 24, 2020
Approved For Pub - Principal Register
Jun 18, 2020
Teas/Email Correspondence Entered
Jun 18, 2020
Correspondence Received In Law Office
Jun 18, 2020
Teas Response To Office Action Received
Dec 19, 2019
Notification Of Non-Final Action E-Mailed
Dec 19, 2019
Non-Final Action E-Mailed
Dec 19, 2019
Non-Final Action Written
Dec 13, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 13, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 14, 2019
Previous Allowance Count Withdrawn
Dec 10, 2019
Withdrawn From Pub - Og Review Query
Nov 27, 2019
Approved For Pub - Principal Register
Nov 21, 2019
Teas/Email Correspondence Entered
Nov 21, 2019
Correspondence Received In Law Office
Nov 18, 2019
Teas Response To Office Action Received
Nov 13, 2019
Teas/Email Correspondence Entered
Nov 13, 2019
Correspondence Received In Law Office
Nov 13, 2019
Teas Response To Office Action Received
Jun 12, 2019
Notification Of Non-Final Action E-Mailed
Jun 12, 2019
Non-Final Action E-Mailed
Jun 12, 2019
Non-Final Action Written
May 21, 2019
Teas/Email Correspondence Entered
May 21, 2019
Correspondence Received In Law Office
May 21, 2019
Teas Response To Office Action Received
Apr 26, 2019
Notification Of Non-Final Action E-Mailed
Apr 26, 2019
Non-Final Action E-Mailed
Apr 26, 2019
Non-Final Action Written
Mar 27, 2019
Teas/Email Correspondence Entered
Mar 27, 2019
Correspondence Received In Law Office
Mar 27, 2019
Teas Response To Suspension Inquiry Received
Mar 27, 2019
Teas/Email Correspondence Entered
Mar 27, 2019
Correspondence Received In Law Office
Mar 26, 2019
Teas Response To Suspension Inquiry Received
Sep 28, 2018
Notification Of Inquiry As To Suspension E-Mailed
Sep 28, 2018
Inquiry To Suspension E-Mailed
Sep 28, 2018
Suspension Inquiry Written
Sep 27, 2018
Suspension Checked - To Attorney For Action
Sep 27, 2018
Assigned To Lie
Mar 7, 2018
Notification Of Letter Of Suspension E-Mailed
Mar 7, 2018
Letter Of Suspension E-Mailed
Mar 7, 2018
Suspension Letter Written
Feb 14, 2018
Teas/Email Correspondence Entered
Feb 13, 2018
Correspondence Received In Law Office
Feb 13, 2018
Teas Response To Suspension Inquiry Received
Nov 7, 2017
Notification Of Letter Of Suspension E-Mailed
Nov 7, 2017
Letter Of Suspension E-Mailed
Nov 7, 2017
Suspension Letter Written
Oct 16, 2017
Teas/Email Correspondence Entered
Oct 16, 2017
Correspondence Received In Law Office
Oct 16, 2017
Teas Response To Suspension Inquiry Received
Sep 22, 2017
Notification Of Letter Of Suspension E-Mailed
Sep 22, 2017
Letter Of Suspension E-Mailed
Sep 22, 2017
Suspension Letter Written
Sep 7, 2017
Teas/Email Correspondence Entered
Sep 7, 2017
Correspondence Received In Law Office
Sep 7, 2017
Teas Response To Office Action Received
Mar 9, 2017
Notification Of Non-Final Action E-Mailed
Mar 9, 2017
Non-Final Action E-Mailed
Mar 9, 2017
Non-Final Action Written
Mar 1, 2017
Assigned To Examiner
Dec 2, 2016
Notice Of Design Search Code E-Mailed
Dec 1, 2016
New Application Office Supplied Data Entered
Nov 26, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
